RISE Global Obesity Industry TOP2+
476310·Stock-Sector-Healthcare
Introduction
The RISE Global Obesity Industry TOP2+ ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the KEDI Global Obesity Care Industry Top2+ Index(Price Return)
Investment Points
ETF Investing in Key Companies for Obesity Treatment, a Global Megatrend
Benchmark Index
KEDI Global Obesity Care Industry Top2+ Index(Price Return)
Benchmark Index Description
This index invests in key companies related to the obesity industry, a global megatrend. It allocates 28% each to Eli Lilly (LLY) and Novo Nordisk (NVO), the first movers in the obesity treatment market, and it is composed of other global pharmaceutical companies and fitness-related companies weighted by market capitalization.
Issuer
KB Asset Management
Brand
RISE
Fee
0.35
Listing Date
2024-02-27
ISIN
KR7476310008
Market Information
Market Capitalization6,838,000,000 KRW
Trading Value19,119,745 KRW
Trading Volume1,821
Number of Listed Shares650,000
NAV10,742
52-Week High11,700 KRW
52-Week Low9,500 KRW